CLINICAL_TRIALS
trial_result
· 2019-09-24
Clinical Trial Update: Omacetaxine for Consolidation and Maintenance [Phase 2]
Summary
Phase 2 clinical trial of omacetaxine for consolidation and maintenance in acute myeloid leukemia has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Acute Myelogenous Leukemia (AML) | Phase 2 | Status: TERMINATED | Results posted: 2019-09-24